The Journal of Pediatrics
Volume 149, Issue 5, Supplement , Pages S89-S96 , November 2006

Dietary lipids and intestinal inflammatory disease

Presented as part of a symposium recognizing the 25th anniversary of the Bristol-Myers Squibb Freedom to Discover Nutrition Grants Program held June 7-8, 2005 at the University of Cincinnati, Cincinnati, OH.

Received 14 April 2006 ,Accepted 1 June 2006.

References 

  1. Cosgrove M, Al-Atia RF, Jenkins HR. The epidemiology of paediatric inflammatory bowel disease. Arch Dis Child. 1996;74:460–461
  2. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307:1920–1925
  3. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182–205
  4. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastoenterol. 1997;92:55–119
  5. Gustot T, Lemmers A, Louis E, Nicoise C, Quertinmont E, Belaiche J, et al. Profile of soluble cytokine receptors in Crohn’s disease. Gut. 2005;54:488–495
  6. Katz JA, Itoh J, Fiocchi C. Pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol. 1999;15:291–297
  7. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Digest Dis Sci. 1996;41:2078–2086
  8. Podolsky DK, Fiocchi C. Cytokines, chemokines, growth factors, eicosanoids and other bioactive molecules in inflammatory bowel disease. In:  Kirsner JB editors. Inflammatory bowel disease. Philadelphia: WB Saunders; 2000;p. 191–207
  9. Koutrobakis I, Manousos ON, Meuwissen SG, Pena AS. Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology. 1996;43:381–393
  10. Armitage E, Drummond HE, Wilson DC, Ghosh S. Increasing incidence of both juvenile-onset Crohn’s disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol. 2001;13:1439–1447
  11. Hassan K, Cowan FJ, Jenkins HR. The incidence of childhood inflammatory disease in Wales. Eur J Pediatr. 2000;159:261–263
  12. Linberg E, Lindquist B, Holmquist L, Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J Pediatr Gastroenterol Nutr. 2000;30:259–264
  13. Pinsk V, Lemberg DA, Leonor R, Barker C, Schreiber R, Israel D, et al. Pediatric inflammatory bowel disease: the British Columbia experience. J Pediatr Gastroenterol Nutr. 2005;41:545
  14. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second- generation South Asians in Leicester (1991-1994). Am J Gastroenterol. 1999;94:2918–2922
  15. Pinsk V, Lemberg DA, Schreiber R, Barker C, Israel D, Jacobson K. The changing pattern of pediatric IBD at British Columbia Children’s Hospital. J Pediatr Gastroenterol Nutr. 2005;41:545
  16. Calder PC. N-3 Polyunsaturated fatty acids and inflammation: from molecular biology to clinic. 2003;38:343–352
  17. Gil A. Polyunsaturated fatty acids and inflammatory disease. Biomed Pharmacother. 2002;56:388–396
  18. Gewirtz AT, Neish AS, Madara JL. Mechanisms of active intestinal inflammation and potential down-regulation via lipoxins. Adv Exp Med Biol. 2002;507:229–236
  19. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2:612–619
  20. Vachier I, Chanez P, Bonnans C, Godard P, Bousquet J, Chavis C. Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. Biochim Biopsy Res Commun. 2002;290:219–224
  21. Serhan CN. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes and resolvins. Curr Opin Clin Nutr Metal Care. 2005;8:115–121
  22. Jia O, Zhou HR, Bennink M, Peska JJ. Docosahexaenoic acid attenuates mycotoxin-induced immunoglobulin a nephropathy, interleukin-6 transcription, and mitogen-activated protein kinase phosphorylation in mice. J Nutr. 2004;134:3343–3349
  23. Denys A, Hichami A, Khan NA. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells. Mol Cell Biochem. 2002;232:143–148
  24. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol. 2003;284:L84–L89
  25. Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med. 2003;34:1006–1016
  26. Mori TA, Beilin LJ. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep. 2004;6:461–467
  27. Shimizu T, Fujii T, Suzuki R, Igarashi J, Ohtsuka Y, Nagata S, et al. Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis. JPGN. 2003;37:581–585
  28. von Schacky C, Fischer S, Weber PC. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest. 1985;76:1626–1631
  29. Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol. 1992;87:432–437
  30. Barbosa DS, Cecchini R, El Kadri MZ, Rodriguez MA, Burini RC, Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition. 2003;9:837–842
  31. Belluzzi A, Boschi S, Brignola C. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr. 2000;71:339S–342S
  32. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med. 1993;334:1557–1560
  33. Hawthorne AB, Daneshmend TK, Hawkey CJ, Belluzzi A, Everitt SJ, Holmes GK, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut. 1992;33:922–928
  34. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel-disease: a randomized placebo-controlled, double-blind, cross-over trial. J Int Med Suppl. 1989;225:225–232
  35. Shoda R, Matsueda K, Yamato S, Umeda N. Therapeutic efficacy of n-3 polyunsaturated fatty acid in experimental Crohn’s disease. J Gastroenterol. 1995;30:895–1015
  36. Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich TL, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med. 1992;116:609–614
  37. Innis SM, Elias SL. Intakes of essential n-6 and n-3 polyunsaturated fatty acids among Canadian pregnant women. Am J Clin Nutr. 2003;77:473–478
  38. Innis SM, Vaghri Z, King DJ. N-6 docosapentaenoic acid is not a predictor of low docosahexaenoic acid status in Canadian preschool children. Am J Clin Nutr. 2004;80:768–773
  39. Raper NR, Cronin FJ, Exler J. Omega-3 fatty acid content of the US food supply. J Am Coll Nutr. 1992;11:304–308
  40. Institute of Medicine of the National Academy of Sciences. Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, D.C: National Academies Press; 2002;
  41. Chow C. In: Fatty acids in foods and their health implications. 2nd ed. New York: Marcel Dekker Inc; 2000;
  42. Cavadini C, Siega Riz AM, Popkin BM. US adolescent food intake trends from 1965 to 1996. Arch Dis Child. 2000;83:18–24
  43. Stephen AM, Sieker GM. Trends in individual fat consumption in the U.K. 1900-1985. Br J Nutr. 1994;71:775–788
  44. Stephen AM, Wald NJ. Trends in individual consumption of dietary fat in the United States, 1920-1984. Am J Clin Nutr. 1990;52:457–469
  45. Popkin BM, Siega-Riz AM, Haines PS, Jahns L. Where’s the fat? (Trends in U.S. diets 1965-1995). Prev Med. 2001;32:245–254
  46. Ekbom A, Helmick , Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991;100:350–358
  47. Fellows IW, Freeman JG, Holmes GKT. Crohn’s disease in the city of Derby, 1951-85. Gut. 1990;31:1262–1265
  48. Kyle J. Crohn’s disease in the Northeastern and Northern Isles of Scotland: an epidemiological review. Gastroenterology. 1992;103:392–399
  49. Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen County from 1962 to 1987. Scand J Gastroenterol. 1991;26:1247–1256
  50. Lapidus A, Bernell O, Hellers G, Persson P-G, Löfberg R. Incidence of Crohn’s disease in Stockholm County 1955-1989. Gut. 1997;41:480–486
  51. Lindberg E, Jarnerot G. The incidence of Crohn’s disease is not decreasing in Sweden. Scand J Gastroenterol. 1991;26:495–500
  52. Loftus EV, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Incidence and prevalence of ulcerative colitis in Olmsted County, Minnesota, 1970-1993. Gastroenterology. 1997;112:A1027
  53. Srivastava ED, Mayberry JF, Morris TJ, Smith PM, Williams GT, Roberts GM, et al. Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut. 1992;33:256–258
  54. Thomas GA, Millar-Jones D, Rhodes J, Roberts GM, Williams GT, Mayberry JF. Incidence of Crohn’s disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol. 1995;7:401–405
  55. Tysk C, Jarnerot G. Ulcerative proctocolitis in Orebro, Sweden (A retrospective epidemiologic study, 1963-1987). Scand J Gastroenterol. 1992;27:945–950
  56. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn’s disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn’s disease in Japan. Am J Clin Nutr. 1996;63:741–745
  57. Innis SM. Perinatal biochemistry and physiology of long chain polyunsaturated fatty acids. J Pediatr. 2003;143:S1–S8
  58. Rahm JJ, Holman RT. Effect of linoleic acid upon the metabolism of linolenic acid. J Nutr. 1964;84:15–19
  59. Jacobson K, Mundra H, Innis SM. Intestinal responsiveness to experimental colitis in young rats is altered by maternal diet. Am J Physiol Gastrointest Liver Physiol. 2005;289:G13–G20
  60. Innis SM. Human milk and formula fatty acids. J Pediatr. 1992;120:S56–S61
  61. Innis SM. Polyunsaturated fatty acids in human milk: an essential role in infant development. Adv Exp Med Biol. 2004;554:27–43
  62. Insull W, Hirsch J, James J, Ahrens EH. The fatty acids of human milk. II (Alterations produced by manipulation of calorie balance and exchange of dietary fats). J Clin Invest. 1959;38:443–450
  63. Innis SM, King DJ. Trans fatty acids in human milk are inversely associated with concentrations of essential all-cis n-6 and n-3 fatty acids and determine trans, but not n-6 and n-3, fatty acids in plasma lipids of breast-fed infants. Am J Clin Nutr. 1999;70:383–390
  64. Innis SM. Essential fatty acid transfer and fetal development. Placenta. 2005;26:S70–S75
  65. Innis SM, de La Presa Owens S. Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain. J Nutr. 2001;131:118–122
  66. Friesen R, Innis SM. Maternal dietary fat alters amniotic fluid and fetal intestinal membrane essential n-6 and n-3 fatty acids in the rat. Am J Physiol Gastrointest Liver Physiol. 2006;290:G505–G510
  67. Nieto N, Torres MI, Rios A, Gil A. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr. 2001;132:11–19
  68. Owen AJ, Peter-Przyborowska BA, Hoy AJ, McLennan PL. Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition. Lipids. 2004;39:955–961
  69. Graham MF. Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn’s disease. Clin Nutr. 2003;22:529–535
  70. Fisher M, Levine PH. Effects of dietary omega-3 fatty acid supplementation in leukocyte free radical production. World Rev Nutr Diet. 1991;66:245–249
  71. Lands WEM, Miller JF, Rich S. Influence of dietary fish oils on plasma (Lipid hydroperoxides). Adv Prostagland Thrombox Leukot Res. 1987;17:876–879
  72. Andoh A, Tsujikawa T, Ishizulea I, Araki Y, Sasaki M, Koyama S, et al. N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in tribitrobenzene sulfonic acid-induced enteritis. Int J Mol Med. 2003;12:721–725
  73. Inui K, Fukuta Y, Ikeda A, Kameda H, Kokubo Y, Saeto M. The nutritional effect of a-linolenic acid-rich emulsion with total parenteral nutrition in a rat model with inflammatory bowel disease. Ann Nutr Metab. 1996;40:227–233
  74. Shimizu T, Igarashi J, Ohtuka Y, Oguchi S, Kaneoko K, Yamashiro Y. Effects of n-3 polyunsaturated fatty acids and vitamin E on colonic mucosal leukotriene generation, lipid peroxidation, and microcirculation in rats with experimental colitis. Digestion. 2001;63:49–54

 Supported by a grant from the Crohn’s Colitis Foundation of Canada and from a “Freedom to Discover” Award from Bristol-Myers Squibb/Mead Johnson.

PII: S0022-3476(06)00618-4

doi: 10.1016/j.jpeds.2006.06.058

The Journal of Pediatrics
Volume 149, Issue 5, Supplement , Pages S89-S96 , November 2006

Article Tools

* Image Usage & Resolution